Dr. Gabriela Gutièrrez, ArgentinaMini-Oral
Lymphoproliferative disease in kidney transplanted children: What has happened over three decades? A single center experience from Argentina.
Dr. Cemile Pehlivanoğlu, TurkeyMini-Oral
The clinical efficacy and safety of Rituximab in pediatric kidney transplant recipients with refractory epstein-barr virus: A case-control study
Mrs. Petrúcia Maria A Pinheiro, BrazilMini-Oral
Pediatric kidney transplantation with deceased donors: A 10-year pioneering experience of hypothermic machine perfusion in Latin America
Miss Angela Hamie, CanadaMini-Oral
Exploring immune maturation in childhood transplantation: influence of age, organ type, thymus excision, and immunosuppression on lymphocyte populations
Dr. Takehisa Ueno, JapanMini-Oral
Mycophenolate mofetil (MMF) effect on anti-HLA donor-specific antibody (DSA) after pediatric living donor transplantation
Dr. Qiang Zhang, People's Republic of ChinaMini-Oral
Clinical features and longitudinal outcomes of COVID-19 in pediatric kidney transplant recipients: A large single-center experience from China
Dr. Meraj Alam Siddiqui, TurkeyMini-Oral
Donor-derived fungal infections in transplant recipients: A case series and literature review of clinical characteristics and outcomes